Exact Mass: 470.9933

Exact Mass Matches: 470.9933

Found 36 metabolites which its exact mass value is equals to given mass value 470.9933, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

8-(4-Chlorophenylthio)-cAMP

6-{6-Amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-2,7-dihydroxytetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-one

C16H15ClN5O6PS (471.0169)


   
   
   
   
   

cladoniamide B

cladoniamide B

C22H15Cl2N3O5 (471.0389)


8a,13-dihydrobenzo[2,3]pyrrolo[3,4:5,6]indolizino[8,7-b]indole-6,8(5aH,7H)-dione which is substituted by chlorines at positions 2 and 10, hydroxy groups at positions 5a and 8a, a methoxy group at position 14, and a methyl group at position 7 (the 5aR,8aS diastereoisomer). It has been isolated from the culture broth of Streptomyces uncialis.

   
   

3,3-dimethyl-4-oxo-1-(4,4,4-trichloro-3-methyl-1-oxobutyl)-5-(3,3,3-trichloro-2-methylpropyl)-2-pyrrolidinone|dysidamide H

3,3-dimethyl-4-oxo-1-(4,4,4-trichloro-3-methyl-1-oxobutyl)-5-(3,3,3-trichloro-2-methylpropyl)-2-pyrrolidinone|dysidamide H

C15H19Cl6NO3 (470.9496)


   

PRZ_M469

PRZ_M469

C15H16Cl3N3O6S (470.9825)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2014

   

Tiotropium Bromide Impurity I

Tiotropium Bromide Impurity I

C19H22BrNO4S2 (471.0174)


   

Fmoc-D-2-(5-Bromothienyl)alanine

Fmoc-D-2-(5-Bromothienyl)alanine

C22H18BrNO4S (471.014)


   

Adenosine-5-diphosphate disodium salt

Adenosine-5-diphosphate disodium salt

C10H13N5Na2O10P2 (470.9933)


Adenosine 5'-diphosphate disodium is a nucleoside diphosphate. Adenosine 5'-diphosphate disodium is the product of ATP dephosphorylation by ATPases. Adenosine 5'-diphosphate disodium is a platelet aggregation agent for hemostasis and the development and extension of arterial thrombosis[1][2].

   

Tiotropium bromide

Tiotropium bromide

C19H22BrNO4S2 (471.0174)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Tiotropium Bromide (BA679 BR) is a muscarinic acetylcholine receptor (mAChR) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel.

   

Fmoc-L-2-(5-Bromothienyl)alanine

Fmoc-L-2-(5-Bromothienyl)alanine

C22H18BrNO4S (471.014)


   

N-(4-iodophenyl)imino-N-(4-nitroanilino)benzenecarboximidamide

N-(4-iodophenyl)imino-N-(4-nitroanilino)benzenecarboximidamide

C19H14IN5O2 (471.0192)


   

adenosine 2,5-diphosphate sodium salt

adenosine 2,5-diphosphate sodium salt

C10H13N5Na2O10P2 (470.9933)


   

Carbamodithioic acid,N,N-dimethyl-, triphenylstannyl ester

Carbamodithioic acid,N,N-dimethyl-, triphenylstannyl ester

C21H21NS2Sn (471.0137)


   
   

(1S,2R,4S,5S,7R)-7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide

(1S,2R,4S,5S,7R)-7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide

C19H22BrNO4S2 (471.0174)


   

Bis(benzonitrile)dichloroplatinum(II)

Bis(benzonitrile)dichloroplatinum(II)

C14H10Cl2N2Pt (470.9869)


   

N-Ethyltridecafluoro-N-(2-hydroxyethyl)-1-hexanesulfonamide

N-Ethyltridecafluoro-N-(2-hydroxyethyl)-1-hexanesulfonamide

C10H10F13NO3S (471.0174)


   

d-myo-inositol 1,4,5-trisphosphate triammonium salt

d-myo-inositol 1,4,5-trisphosphate triammonium salt

C6H24N3O15P3 (471.042)


   

8-(4-Chlorophenylthio)-cAMP

8-(4-Chlorophenylthio)-cAMP

C16H15ClN5O6PS (471.0169)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents D004791 - Enzyme Inhibitors

   
   

2,4,6-trichloro-3-{2-[(1H-imidazole-1-carbonyl)(propyl)amino]ethoxy}phenyl hydrogen sulfate

2,4,6-trichloro-3-{2-[(1H-imidazole-1-carbonyl)(propyl)amino]ethoxy}phenyl hydrogen sulfate

C15H16Cl3N3O6S (470.9825)


   

6-bromo-2-(3-pyridinyl)-N-[4-(trifluoromethyl)phenyl]-4-quinolinecarboxamide

6-bromo-2-(3-pyridinyl)-N-[4-(trifluoromethyl)phenyl]-4-quinolinecarboxamide

C22H13BrF3N3O (471.0194)


   

2-[[5-(5-Bromo-2-furanyl)-4-(phenylmethyl)-1,2,4-triazol-3-yl]thio]-1-(2-fluorophenyl)ethanone

2-[[5-(5-Bromo-2-furanyl)-4-(phenylmethyl)-1,2,4-triazol-3-yl]thio]-1-(2-fluorophenyl)ethanone

C21H15BrFN3O2S (471.0052)


   

N-(1,3-benzodioxol-5-ylmethyl)-2-(3-methyl-4-oxo-5-thiophen-2-ylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide

N-(1,3-benzodioxol-5-ylmethyl)-2-(3-methyl-4-oxo-5-thiophen-2-ylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide

C21H17N3O4S3 (471.0381)


   

(4aS,6S,7S,7aR)-6-[6-amino-8-[(4-chlorophenyl)thio]-9-purinyl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-ol

(4aS,6S,7S,7aR)-6-[6-amino-8-[(4-chlorophenyl)thio]-9-purinyl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphorin-7-ol

C16H15ClN5O6PS (471.0169)


   

Adenosine 3',5'-diphosphate (disodium)

Adenosine 3',5'-diphosphate (disodium)

C10H13N5Na2O10P2 (470.9933)


Adenosine 3',5'-diphosphate disodium is an hydroxysteroid sulfotransferases inhibitor[1].

   

3,3-dimethyl-5-(3,3,3-trichloro-2-methylpropyl)-1-(4,4,4-trichloro-3-methylbutanoyl)pyrrolidine-2,4-dione

3,3-dimethyl-5-(3,3,3-trichloro-2-methylpropyl)-1-(4,4,4-trichloro-3-methylbutanoyl)pyrrolidine-2,4-dione

C15H19Cl6NO3 (470.9496)


   

4-bromo-n-(3-{2-bromo-4-[2-(dimethylamino)ethyl]phenoxy}propyl)-1h-pyrrole-2-carboxamide

4-bromo-n-(3-{2-bromo-4-[2-(dimethylamino)ethyl]phenoxy}propyl)-1h-pyrrole-2-carboxamide

C18H23Br2N3O2 (471.0157)


   

alpinoside a

NA

C19H22BrNO4S2 (471.0174)


{"Ingredient_id": "HBIN015757","Ingredient_name": "alpinoside a","Alias": "NA","Ingredient_formula": "C19H22BrNO4S2","Ingredient_Smile": "C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "990","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-bromo-n-(2-{3-bromo-4-[3-(dimethylamino)propoxy]phenyl}ethyl)-1h-pyrrole-2-carboxamide

4-bromo-n-(2-{3-bromo-4-[3-(dimethylamino)propoxy]phenyl}ethyl)-1h-pyrrole-2-carboxamide

C18H23Br2N3O2 (471.0157)


   

(5r)-3,3-dimethyl-5-[(2r)-3,3,3-trichloro-2-methylpropyl]-1-[(3s)-4,4,4-trichloro-3-methylbutanoyl]pyrrolidine-2,4-dione

(5r)-3,3-dimethyl-5-[(2r)-3,3,3-trichloro-2-methylpropyl]-1-[(3s)-4,4,4-trichloro-3-methylbutanoyl]pyrrolidine-2,4-dione

C15H19Cl6NO3 (470.9496)


   

7,20-dichloro-11,15-dihydroxy-23-methoxy-13-methyl-3,13,16-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(23),2(10),4,6,8,17,19,21-octaene-12,14-dione

7,20-dichloro-11,15-dihydroxy-23-methoxy-13-methyl-3,13,16-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(23),2(10),4,6,8,17,19,21-octaene-12,14-dione

C22H15Cl2N3O5 (471.0389)